-
Understanding the role of B-cells in CAR T-cell therapy in leukemia through a mathematical model
Authors:
Sergio Serrano,
Roberto Barrio,
Álvaro Martínez-Rubio,
Juan Belmonte-Beitia,
Víctor M. Pérez-García
Abstract:
Chimeric Antigen Receptor T (CAR-T) cell therapy has been proven to be successful against different leukaemias and lymphomas. This paper makes an analytical and numerical study of a mathematical model describing the competition of CAR-T, leukaemias tumor and B cells. Considering its significance in sustaining anti-CD19 CAR T-cell stimulation, we integrate a B-cell source term into the model. Throu…
▽ More
Chimeric Antigen Receptor T (CAR-T) cell therapy has been proven to be successful against different leukaemias and lymphomas. This paper makes an analytical and numerical study of a mathematical model describing the competition of CAR-T, leukaemias tumor and B cells. Considering its significance in sustaining anti-CD19 CAR T-cell stimulation, we integrate a B-cell source term into the model. Through stability and bifurcation analyses, we reveal the potential for tumor eradication contingent on the continuous influx of B-cells, uncovering a transcritical bifurcation at a critical B-cell input. Additionally, we identify an almost heteroclinic cycle between equilibrium points, providing a theoretical basis for understanding disease relapse. Analyzing the oscillatory behavior of the system, we approximate the time-dependent dynamics of CAR T-cells and leukemic cells, shedding light on the impact of initial tumor burden on therapeutic outcomes. In conclusion, our study provides insights into CAR T-cell therapy dynamics for acute lymphoblastic leukemias, offering a theoretical foundation for clinical observations and suggesting avenues for future immunotherapy modeling research.
△ Less
Submitted 1 March, 2024;
originally announced March 2024.
-
Mathematical Modeling of Leukemia Chemotherapy in Bone Marrow
Authors:
Ana Niño-López,
Salvador Chulián,
Álvaro Martínez-Rubio,
Cristina Blázquez-Goñi,
María Rosa
Abstract:
Acute Lymphoblastic Leukemia (ALL) accounts for the 80% of leukemias when coming down to pediatric ages. Survival of these patients has increased by a considerable amount in recent years. However, around 15-20% of treatments are unsuccessful. For this reason, it is definitely required to come up with new strategies to study and select which patients are at higher risk of relapse. Thus the importan…
▽ More
Acute Lymphoblastic Leukemia (ALL) accounts for the 80% of leukemias when coming down to pediatric ages. Survival of these patients has increased by a considerable amount in recent years. However, around 15-20% of treatments are unsuccessful. For this reason, it is definitely required to come up with new strategies to study and select which patients are at higher risk of relapse. Thus the importance to monitor the amount of leukemic cells to predict relapses in the first treatment phase. In this work we develop a mathematical model describing the behavior of ALL, examining the evolution of a leukemic clone when treatment is applied. In the study of this model it can be observed how the risk of relapse is connected with the response in the first treatment phase. This model is able to simulate cell dynamics without treatment, representing a virtual patient bone marrow behavior. Furthermore, several parameters are related to treatment dynamics, therefore proposing a basis for future works regarding childhood ALL survival improvement.
△ Less
Submitted 24 November, 2022;
originally announced November 2022.
-
Dynamical properties of feedback signalling in B lymphopoiesis: A mathematical modelling approach
Authors:
Salvador Chulián,
Alvaro Martínez-Rubio,
Anna Marciniak-Czochra,
Thomas Stiehl,
Cristina Blázquez Goñi,
Juan Francisco Rodríguez Gutiérrez,
Manuel Ramirez Orellana,
Ana Castillo Robleda,
Víctor M. Pérez-García,
María Rosa
Abstract:
Haematopoiesis is the process of generation of blood cells. Lymphopoiesis generates lymphocytes, the cells in charge of the adaptive immune response. Disruptions of this process are associated with diseases like leukaemia, which is especially incident in children. The characteristics of self-regulation of this process make them suitable for a mathematical study.
In this paper we develop mathemat…
▽ More
Haematopoiesis is the process of generation of blood cells. Lymphopoiesis generates lymphocytes, the cells in charge of the adaptive immune response. Disruptions of this process are associated with diseases like leukaemia, which is especially incident in children. The characteristics of self-regulation of this process make them suitable for a mathematical study.
In this paper we develop mathematical models of lymphopoiesis using currently available data. We do this by drawing inspiration from existing structured models of cell lineage development and integrating them with paediatric bone marrow data, with special focus on regulatory mechanisms. A formal analysis of the models is carried out, giving steady states and their stability conditions. We use this analysis to obtain biologically relevant regions of the parameter space and to understand the dynamical behaviour of B-cell renovation. Finally, we use numerical simulations to obtain further insight into the influence of proliferation and maturation rates on the reconstitution of the cells in the B line. We conclude that a model including feedback regulation of cell proliferation represents a biologically plausible depiction for B-cell reconstitution in bone marrow. Research into haematological disorders could benefit from a precise dynamical description of B lymphopoiesis.
△ Less
Submitted 8 July, 2020;
originally announced July 2020.
-
CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models
Authors:
Odelaisy Leon-Triana,
Soukaina Sabir,
Gabriel F. Calvo,
Juan Belmonte-Beitia,
Salvador Chulian,
Alvaro Martinez-Rubio,
Maria Rosa,
Antonio Perez-Martinez,
Manuel Ramirez Orellana,
Victor M. Perez-Garcia
Abstract:
Immunotherapies use components of the patient immune system to selectively target cancer cells. The use of CAR T cells to treat B-cell malignancies --leukaemias and lymphomas-- is one of the most successful examples, with many patients experiencing long-lasting complete responses to this therapy. This treatment works by extracting the patient's T cells and adding them the CAR group, which enables…
▽ More
Immunotherapies use components of the patient immune system to selectively target cancer cells. The use of CAR T cells to treat B-cell malignancies --leukaemias and lymphomas-- is one of the most successful examples, with many patients experiencing long-lasting complete responses to this therapy. This treatment works by extracting the patient's T cells and adding them the CAR group, which enables them to recognize and target cells carrying the antigen CD19+, that is expressed in these haematological tumors.
Here we put forward a mathematical model describing the time response of leukaemias to the injection of CAR T-cells. The model accounts for mature and progenitor B-cells, tumor cells, CAR T cells and side effects by incorporating the main biological processes involved. The model explains the early post-injection dynamics of the different compartments and the fact that the number of CAR T cells injected does not critically affect the treatment outcome. An explicit formula is found that provides the maximum CAR T cell expansion in-vivo and the severity of side effects. Our mathematical model captures other known features of the response to this immunotherapy. It also predicts that CD19+ tumor relapses could be the result of the competition between tumor and CAR T cells analogous to predator-prey dynamics. We discuss this fact on the light of available evidences and the possibility of controlling relapses by early re-challenging of the tumor with stored CAR T cells.
△ Less
Submitted 27 August, 2020; v1 submitted 18 March, 2020;
originally announced March 2020.